Rexahn Pharmaceuticals names VC vet to board of directors
Rexahn Pharmaceuticals has named Mark P. Carthy to its board of directors. Carthy is the managing partner of Orion Equity Partners, a healthcare venture firm. Headquartered in Rockville, Maryland, Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company focused on treating cancer.
3 March 2014•2 mins read
